Yoshitaka Narita

Also affiliated with National Cancer Center Hospital East, Tokyo National Hospital, National Cancer Research Institute

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 3 papers. Top paper: “Glioblastomas withIDH1/2mutations have a short clinical history and have a favorable clinical outcome”.

Glioblastomas withIDH1/2mutations have a short clinical history and have a favorable clinical outcome

Japanese Journal of Clinical Oncology(2016)10.1093/jjco/hyv170

N/A

0.905DataRank · unranked

15 citations

Yoshitaka Narita, Yasuji Miyakita, Yuko Matsushita, Hideyuki Arita, Motoki Yonezawa +6 more

Validation study of the Japanese version of MD Anderson Symptom Inventory for Brain Tumor module

Japanese Journal of Clinical Oncology(2020)10.1093/jjco/hyaa036

N/A

0DataRank · unranked

6 citations

Iori Sato, Masamichi Takahashi, Terri S. Armstrong, Charles S. Cleeland, Tito R. Mendoza +6 more

Evidence-based recommendations on categories for extent of resection in diffuse glioma

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.002

N/A

0DataRank · unranked

209 citations

Michael A. Vogelbaum, Martin J. van den Bent, Daniel P. Cahill, Lorenzo Bello, Yoshitaka Narita +4 more